New York State Common Retirement Fund
RAPP

New York State Common Retirement Fund’s Rapport Therapeutics RAPP Stock Holding History

New York State Common Retirement Fund’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$344K Buy
11,000
+3,700
+51% +$104K ﹤0.01% 2042
2025
Q4 		$221K Hold
7,300
– – ﹤0.01% 2256
2025
Q3 		$217K Buy
7,300
+3,800
+109% +$67.8K ﹤0.01% 2259
2025
Q2 		$39.8K Hold
3,500
– – ﹤0.01% 3002
2025
Q1 		$35.1K Hold
3,500
– – ﹤0.01% 2876
2024
Q4 		$62.1K Buy
+3,500
New +$77.6K ﹤0.01% 2790

Other funds holding RAPP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

New York State Common Retirement Fund's RAPP Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Rapport Therapeutics (RAPP) stake by 51% in Q1 2026, buying an estimated $104K and bringing the position to 11,000 shares worth $344K. The position accounts for ﹤0.01% of the portfolio, ranked #2042.

New York State Common Retirement Fund first reported a position in RAPP in Q4 2024 and has held it in 6 quarters since. 147 funds tracked by Wall St. Rank hold RAPP as of Q1 2026.

  • New York State Common Retirement Fund held 11,000 shares of Rapport Therapeutics worth $344K as of Q1 2026.
  • New York State Common Retirement Fund bought 3,700 Rapport Therapeutics shares in Q1 2026, an estimated $104K.
  • Rapport Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2042 holding.
  • New York State Common Retirement Fund first reported a position in Rapport Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 147 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.